Piokare-MSR 15mg/500mg Tablet
By Piokare-M
Rx
10 Tablet SR in a Strip

Composition
Pioglitazone(15mg) + Metformin(500mg)

Manufacturer - Nitro Cadineur
#162, 2nd Floor, Jeevan Nagar, Kilokari Ashram, NEW DELHI 122 014 India

Expires on or after
October, 2025

liver
When taking Piokare-MSR 15mg/500mg Tablet, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment, so it's advisable to consult your doctor before starting this medication. Typically, Piokare-MSR 15mg/500mg Tablet is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not recommended for use in patients with severe liver disease. Always seek guidance from a healthcare professional regarding the appropriate use of Piokare-MSR 15mg/500mg Tablet if you have liver-related concerns.

kidney
Piokare-MSR 15mg/500mg Tablet should be used carefully in patients with kidney disease. Dose adjustment may be necessary, and consulting your doctor is important. It is not recommended for those with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

alcohol
Do not consume alcohol with Piokare-MSR 15mg/500mg Tablet.

driving
Driving while taking Piokare-MSR 15mg/500mg Tablet may be impacted if you experience low or high blood sugar levels. Avoid driving if these symptoms occur.

pregnancy
Piokare-MSR 15mg/500mg Tablet may not be safe to use during pregnancy as animal studies have shown potential harm to the developing baby. Your doctor will evaluate the benefits and risks before prescribing it. Please consult your doctor for more information.

breastfeeding
Piokare-MSR 15mg/500mg Tablet is likely unsafe during breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby. It is advisable to consult your doctor before use.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹48
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024